Ginkgo Bioworks Holdings Inc vs Roundhill Russell 2000 0DTE Covered Call Strat ETF — how do they compare? Ginkgo Bioworks Holdings Inc trades at $11.53 (market cap $772.39M), while Roundhill Russell 2000 0DTE Covered Call Strat ETF trades at $25.96 (market cap $176.64M). The key difference: Ginkgo Bioworks Holdings Inc is far larger — about 4.4× Roundhill Russell 2000 0DTE Covered Call Strat ETF's market cap, and Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, Roundhill Russell 2000 0DTE Covered Call Strat ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and Roundhill Russell 2000 0DTE Covered Call Strat ETF for 53 Days on average.
| DNA | RDTE | |
|---|---|---|
Market Cap | $772.39M | $176.64M |
Volume | 6,453,273 | 116,818 |
Sector | Health | Income / Options Overlay |
52-Week High | $15.83 | $33.66 |
52-Week Low | $5.48 | $25.96 |
Typical Hold Time | 7 Days | 53 Days |
Enterprise Value | $874.34M | — |
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $11.47, down 7.57% on the day, with a bullish technical signal from moving averages but mixed earnings performance. The company reported a net loss of $312.76 million on $170.16 million revenue in 2025, with a high gross margin of 68.04% but negative net income margin. Recent news includes a $17.5 million ARPA-H subcontract for RNA medicine manufacturing, highlighting growth initiatives amid financial challenges.
The outlook remains speculative with significant cash burn and persistent losses, though partnerships and government contracts offer potential catalysts. Risks include high operating costs and reliance on funding, while analyst sentiment is divided equally between buy, hold, and sell ratings. Investment hinges on the company's ability to monetize its technology and achieve profitability.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →RDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the Russell 2000 Index. The fund primarily holds a portfolio of short-term U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the Russell 2000. This highly tactical strategy aims to maximize premium capture by exploiting the high time decay of options that are expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.
Read more on RDTE →